Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 36Kidney Neoplasms 9Neoplasm Metastasis 7Neoplasms 6Melanoma 5Colorectal Neoplasms 5Glioblastoma 4Carcinoma, Hepatocellular 4Recurrence 3Clear-cell metastatic renal cell carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Liver Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Adenoid Cystic 2cT2a N0NxM0 Renal Tumor 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Solitary Fibrous Tumors 1Solid Malignancies 1Skin Neoplasms 1Sarcoma, Alveolar Soft Part 1Salivary Gland Neoplasms 1Relapsed Pediatric Solid Tumor 1Radiation Therapy 1Prostatic Neoplasms 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1

Interventions

Indocyanine Green 7Surgical Procedures, Operative 5Lymph Node Excision 5Radiotherapy, Intensity-Modulated 4Radiotherapy 4Radiosurgery 4Cisplatin 4gadofosveset trisodium 2TP protocol 2Sentinel Lymph Node Biopsy 2Radiation Dose Hypofractionation 2Magnetic Resonance Spectroscopy 2Electroporation 2Conversion to Open Surgery 2Control Groups 2Chemotherapy, Adjuvant 2Chemoradiotherapy 2Artificial Intelligence 2tislelizumab 1sarcolipin 1lncRNA LNMAT1, human 1gewf solution 1fluoroazomycin arabinoside 1X-Rays 1Technetium-99 1Technetium 1Surgery, Computer-Assisted 1Spectrum Analysis 1Specimen Handling 1Robotic Surgical Procedures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphatic Metastasis × Axitinib × Clear all
NCT01409200 2026-03-03

Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis

M.D. Anderson Cancer Center

Phase 2 Completed
73 enrolled

Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡